vs
Side-by-side financial comparison of Dianthus Therapeutics, Inc. (DNTH) and MICROVISION, INC. (MVIS). Click either name above to swap in a different company.
Dianthus Therapeutics, Inc. is the larger business by last-quarter revenue ($284.0K vs $223.0K, roughly 1.3× MICROVISION, INC.). On growth, Dianthus Therapeutics, Inc. posted the faster year-over-year revenue change (-78.6% vs -86.5%). Dianthus Therapeutics, Inc. produced more free cash flow last quarter ($-47.1M vs $-59.4M). Over the past eight quarters, Dianthus Therapeutics, Inc.'s revenue compounded faster (-44.6% CAGR vs -51.7%).
Dianthus Therapeutics is a clinical-stage biopharmaceutical firm focused on developing targeted therapies for rare immunological and inflammatory diseases. It advances antibody-based candidates to address unmet needs of severe patients, operating primarily in the U.S. with global development partners.
MicroVision Inc. is a technology company specializing in advanced LiDAR sensors, miniature display solutions, and perception software. Its core products serve automotive ADAS, augmented reality devices, consumer electronics, and industrial automation markets, delivering high-precision, low-power sensing technologies for next-generation smart applications.
DNTH vs MVIS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0K | $223.0K |
| Net Profit | $-64.4M | — |
| Gross Margin | — | — |
| Operating Margin | -24486.3% | — |
| Net Margin | -22687.3% | — |
| Revenue YoY | -78.6% | -86.5% |
| Net Profit YoY | -126.6% | -21.2% |
| EPS (diluted) | $-1.53 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0K | $223.0K | ||
| Q3 25 | $396.0K | $241.0K | ||
| Q2 25 | — | $155.0K | ||
| Q1 25 | $1.2M | $589.0K | ||
| Q4 24 | $1.3M | $1.6M | ||
| Q3 24 | $2.2M | $190.0K | ||
| Q2 24 | $1.9M | $1.9M | ||
| Q1 24 | $874.0K | $956.0K |
| Q4 25 | $-64.4M | — | ||
| Q3 25 | $-36.8M | $-14.2M | ||
| Q2 25 | — | $-14.2M | ||
| Q1 25 | $-29.5M | $-28.8M | ||
| Q4 24 | $-28.4M | $-31.2M | ||
| Q3 24 | $-25.2M | $-15.5M | ||
| Q2 24 | $-17.6M | $-23.9M | ||
| Q1 24 | $-13.7M | $-26.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 6.6% | ||
| Q4 24 | — | -149.5% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 18.2% | ||
| Q1 24 | — | -33.6% |
| Q4 25 | -24486.3% | — | ||
| Q3 25 | -10173.7% | -5278.4% | ||
| Q2 25 | — | -9455.5% | ||
| Q1 25 | -2852.7% | -2383.7% | ||
| Q4 24 | -2406.9% | -1119.5% | ||
| Q3 24 | -1376.6% | -8266.3% | ||
| Q2 24 | -1191.8% | -1296.4% | ||
| Q1 24 | -2041.6% | -2793.9% |
| Q4 25 | -22687.3% | — | ||
| Q3 25 | -9284.1% | -5899.2% | ||
| Q2 25 | — | -9180.0% | ||
| Q1 25 | -2537.5% | -4886.1% | ||
| Q4 24 | -2144.8% | -1888.2% | ||
| Q3 24 | -1159.0% | -8166.8% | ||
| Q2 24 | -945.1% | -1259.5% | ||
| Q1 24 | -1573.0% | -2752.4% |
| Q4 25 | $-1.53 | — | ||
| Q3 25 | $-0.97 | $-0.05 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | $-0.82 | $-0.12 | ||
| Q4 24 | $-0.76 | $-0.15 | ||
| Q3 24 | $-0.74 | $-0.07 | ||
| Q2 24 | $-0.51 | $-0.11 | ||
| Q1 24 | $-0.54 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $404.3M | $74.9M |
| Total DebtLower is stronger | — | $19.2M |
| Stockholders' EquityBook value | $493.4M | $55.5M |
| Total Assets | $530.9M | $103.1M |
| Debt / EquityLower = less leverage | — | 0.35× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $404.3M | $74.9M | ||
| Q3 25 | $402.6M | $99.5M | ||
| Q2 25 | — | $91.4M | ||
| Q1 25 | $263.2M | $69.0M | ||
| Q4 24 | $275.2M | $74.7M | ||
| Q3 24 | $281.1M | $43.2M | ||
| Q2 24 | $360.7M | $56.6M | ||
| Q1 24 | $377.0M | $73.1M |
| Q4 25 | — | $19.2M | ||
| Q3 25 | — | $29.0M | ||
| Q2 25 | — | $32.3M | ||
| Q1 25 | — | $30.1M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $493.4M | $55.5M | ||
| Q3 25 | $546.5M | $90.7M | ||
| Q2 25 | — | $77.1M | ||
| Q1 25 | $328.6M | $53.2M | ||
| Q4 24 | $352.5M | $48.8M | ||
| Q3 24 | $337.9M | $65.9M | ||
| Q2 24 | $358.2M | $78.7M | ||
| Q1 24 | $372.7M | $93.8M |
| Q4 25 | $530.9M | $103.1M | ||
| Q3 25 | $577.4M | $150.8M | ||
| Q2 25 | — | $140.6M | ||
| Q1 25 | $348.6M | $116.7M | ||
| Q4 24 | $374.0M | $121.2M | ||
| Q3 24 | $354.2M | $88.3M | ||
| Q2 24 | $369.0M | $103.4M | ||
| Q1 24 | $382.5M | $124.2M |
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.42× | ||
| Q1 25 | — | 0.57× | ||
| Q4 24 | — | 0.68× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-47.0M | $-58.7M |
| Free Cash FlowOCF − Capex | $-47.1M | $-59.4M |
| FCF MarginFCF / Revenue | -16591.9% | -26636.3% |
| Capex IntensityCapex / Revenue | 48.6% | 304.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-132.8M | $-103.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-47.0M | $-58.7M | ||
| Q3 25 | $-30.6M | $-16.5M | ||
| Q2 25 | — | $-12.7M | ||
| Q1 25 | $-27.6M | $-14.1M | ||
| Q4 24 | $-27.4M | $-15.1M | ||
| Q3 24 | $-21.3M | $-14.1M | ||
| Q2 24 | $-14.5M | $-18.6M | ||
| Q1 24 | $-14.9M | $-20.8M |
| Q4 25 | $-47.1M | $-59.4M | ||
| Q3 25 | $-30.6M | $-16.6M | ||
| Q2 25 | — | $-12.9M | ||
| Q1 25 | $-27.7M | $-14.2M | ||
| Q4 24 | $-27.5M | $-15.2M | ||
| Q3 24 | $-21.3M | $-14.1M | ||
| Q2 24 | $-14.5M | $-18.8M | ||
| Q1 24 | $-15.0M | $-20.9M |
| Q4 25 | -16591.9% | -26636.3% | ||
| Q3 25 | -7717.2% | -6894.6% | ||
| Q2 25 | — | -8346.5% | ||
| Q1 25 | -2377.8% | -2410.4% | ||
| Q4 24 | -2072.0% | -918.7% | ||
| Q3 24 | -980.3% | -7421.1% | ||
| Q2 24 | -780.7% | -989.5% | ||
| Q1 24 | -1713.2% | -2183.4% |
| Q4 25 | 48.6% | 304.5% | ||
| Q3 25 | 1.3% | 53.1% | ||
| Q2 25 | — | 134.2% | ||
| Q1 25 | 2.1% | 16.8% | ||
| Q4 24 | 2.3% | 6.2% | ||
| Q3 24 | 1.2% | 4.7% | ||
| Q2 24 | 0.9% | 8.7% | ||
| Q1 24 | 3.7% | 11.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
